IM Cannabis Closes $1.31M Offering at $2.00, Director-Linked Firm Takes 25%
IMCC has more than doubled off its 52-week low of $1.55.
Summary
IM Cannabis closed its $1.31 million registered direct offering, selling 655,000 shares at $2.00 each. The price is a steep discount to the current $3.15 market price, reflecting the company's distressed financial position. Notably, Invest-Pro, a firm where director Eli Zamir also serves as a director, bought 164,585 shares for $329,170, representing about 25% of the offering. The company relied on financial hardship exemptions to avoid minority shareholder approval for this related party transaction, underscoring its liquidity crisis. This follows a pattern of deeply dilutive financings and a going concern warning from August. The offering adds significant dilution to a micro-cap stock already under Nasdaq delisting risk.
Updates
· SEC 6-K — The 6-K attaches the press release and confirms the offering closed on September 24, 2026, with Invest-Pro buying 164,585 shares for $329,170.
At the time of this announcement, IMCC was trading at $3.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9M. The 52-week trading range was $1.55 to $77.10. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.